News tagged with indomethacin
Indometacin
Indometacin (INN) or indomethacin (USAN and former BAN) is a non-steroidal anti-inflammatory drug commonly used to reduce fever, pain, stiffness, and swelling. It works by inhibiting the production of prostaglandins, molecules known to cause these symptoms. It is marketed under many trade names, including Indocin, Indocid, Indochron E-R, and Indocin-SR.
For more information about Indometacin, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
New analysis of the cardiovascular risks of common non-steroidal anti-inflammatory drugs
An updated study published in this week's PLoS Medicine gives some new information on the cardiovascular risks of non-steroidal anti-inflammatory drugs (NSAIDs) and suggests that among these commonly used drugs, naproxen and lo ...
Medicine & Health / Cardiology
Sep 27, 2011 |
5 / 5 (1) |
0
Erectile dysfunction linked to aspirin and other NSAIDs
Daily use of aspirin and other nonsteroidal anti-inflammatory drugs, commonly known as NSAIDs, is associated with a 22 percent increase in the risk of erectile dysfunction, Kaiser researchers found in a study of more ...
Mar 08, 2011 |
5 / 5 (3) |
0
Fast-tracking the manufacture of glasses
Old glass is not the same as new glass -- and the difference is not just due to manufacturing techniques. Unlike crystalline solids, glasses change as they age, increasing packing density and stability. Ideally, a glass should ...
Jun 29, 2010 |
5 / 5 (5) |
0
Fluorescent compounds make tumors glow
A series of novel imaging agents could light up tumors as they begin to form - before they turn deadly - and signal their transition to aggressive cancers.
Apr 29, 2010 |
5 / 5 (3) |
0
|
Inflammation may trigger Alzheimer's disease
The anti-inflammatory drug indomethacin could hold promise as a treatment for Alzheimer's disease, says a Saint Louis University doctor and researcher.
Jul 08, 2009 |
5 / 5 (1) |
0
New 'microcapsules' put more medication into the bloodstream to treat disease
Scientists are reporting a potential solution to a problem that limits the human body’s ability to absorb and use medications for heart disease, Type-2 diabetes, cancer and other conditions. It is a “nano-hybrid ...
May 27, 2009 |
5 / 5 (2) |
0
